Outset Medical, Inc. income statement

In fiscal 2025, Outset Medical, Inc. reported revenue of $119m, up 5.1% on the year before, operating income of −$66.7m (a -55.8% margin) and net income of −$81.7m, or −$5.37 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Outset Medical, Inc.: income statement, annual
Fiscal year	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	2	15	50	103	115	130	114	119	118
Cost of revenue	8	33	63	95	98	101	75	73	69
Gross profit	−6	−18	−13	8	18	29	39	47	49
Research and development	23	23	29	37	49	57	38	21	21
Selling and marketing	11	20	45	65	89	96	70	54	52
General and administrative	6	9	31	36	41	45	43	38	42
Operating income	−47	−70	−117	−131	−161	−170	−113	−67	−66
Interest expense	5	4	3	2	4	13	24	14	14
Income before tax	−50	−68	−121	−132	−163	−172	−127	−81	−73
Income tax	0	0	0	0	0	1	0	1	1
Net income	−50	−68	−121	−132	−163	−173	−128	−82	−74
Diluted EPS	−$1511.25	−$1493.70	−$72.75	−$43.35	−$50.70	−$52.28	−$36.96	−$5.37	−$4.07
Diluted shares (average)	—	57m	—	—	—	—	—	15m	18m
EBITDA	−45	−69	−114	−125	−156	−164	−108	−62	−63

US$ millions unless shown otherwise. Fiscal quarters.

Outset Medical, Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	29	29	30	31	29	29	28	32
Cost of revenue	19	19	19	20	18	17	16	18
Gross profit	10	11	11	12	12	12	12	13
Research and development	8	8	6	5	5	5	6	5
Selling and marketing	15	15	14	14	14	13	13	12
General and administrative	10	9	8	9	8	12	10	11
Operating income	−24	−22	−16	−17	−16	−18	−17	−16
Interest expense	6	6	4	3	3	3	3	3
Income before tax	−28	−26	−26	−18	−17	−19	−19	−18
Income tax	0	−0	0	0	0	0	0	0
Net income	−28	−26	−26	−19	−18	−19	−19	−18
Diluted EPS	−$4.01	−$3.63	−$3.66	−$1.04	−$1.00	−$1.00	−$1.03	−$0.97
EBITDA	−22	−20	−15	−16	−15	−17	−16	−15

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ANIK vs OM OM vs OWLT OM vs SMTI BBNX vs OM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Outset Medical, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Outset Medical, Inc.